Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review.

We summarize the existing evidence on the potential benefit of oral anticoagulation (OAC) in intracerebral hemorrhage (ICH) survivors with nonvalvular atrial fibrillation (NVAF).